Skip Navigation

Publication Detail

Title: Pharmacodynamics of dietary phytochemical indoles I3C and DIM: Induction of Nrf2-mediated phase II drug metabolizing and antioxidant genes and synergism with isothiocyanates.

Authors: Saw, Constance Lay-Lay; Cintrón, Melvilí; Wu, Tien-Yuan; Guo, Yue; Huang, Ying; Jeong, Woo-Sik; Kong, Ah-Ng Tony

Published In Biopharm Drug Dispos, (2011 Jul)

Abstract: The antioxidant response element (ARE) is a critical regulatory element for the expression of many phase II drug metabolizing enzymes (DME), phase III transporters and antioxidant enzymes, mediated by the transcription factor Nrf2. The aim of this study was to examine the potential activation and synergism of Nrf2-ARE-mediated transcriptional activity between four common phytochemicals present in cruciferous vegetables; the indoles: indole-3-carbinol (I3C), 3,3'-diindolylmethane (DIM); and the isothiocyanates (ITCs): phenethyl isothiocyanate (PEITC) and sulforaphane (SFN). The cytotoxicity of the compounds was determined in a human liver hepatoma cell line (HepG2-C8). The combination index was calculated to assess the synergistic effects on the induction of ARE-mediated gene expressions. Quantitative real-time polymerase chain reaction (qPCR) was employed to measure the mRNA expressions of Nrf2 and Nrf2-mediated genes. I3C and DIM showed less cytotoxicity than SFN and PEITC. Compared with I3C, DIM was found to be a stronger inducer of ARE. Synergism was observed after combined treatments of 6.25 µm I3C + 1 µm SFN, 6.25 µm I3C + 1 µm PEITC and 6.25 µm DIM + 1 µm PEITC, while an additive effect was observed for 6.25 µm DIM + 1 µm SFN. Induction of endogenous Nrf2, phase II genes (GSTm2, UGT1A1 and NQO1) and antioxidant genes (HO-1 and SOD1) was also observed. In summary, the indole I3C or DIM alone could induce or syngergistically induce in combination with the ITCs SFN or PEITC, Nrf2-ARE-mediated gene expression, which could potentially enhance cancer chemopreventive activity.

PubMed ID: 21656528 Exiting the NIEHS site

MeSH Terms: Anticarcinogenic Agents/pharmacology; Antioxidants/metabolism*; Carcinoma, Hepatocellular/genetics; Carcinoma, Hepatocellular/pathology; Drug Synergism; Gene Expression Regulation, Neoplastic/drug effects; Hep G2 Cells; Humans; Indoles/pharmacology*; Isothiocyanates/pharmacology*; Liver Neoplasms/genetics; Liver Neoplasms/pathology; NF-E2-Related Factor 2/drug effects; NF-E2-Related Factor 2/genetics; Polymerase Chain Reaction; RNA, Messenger/metabolism; Response Elements/drug effects; Response Elements/genetics

Back
to Top